Connect with us

Uncategorized

Biotechnology reagents market size to increase by USD 36,019.44 million; North America to account for 48% of market growth – Technavio

Biotechnology reagents market size to increase by USD 36,019.44 million; North America to account for 48% of market growth – Technavio
PR Newswire
NEW YORK, Jan. 24, 2023

NEW YORK, Jan. 24, 2023 /PRNewswire/ — The Biotechnology Reagents Market by …

Published

on

Biotechnology reagents market size to increase by USD 36,019.44 million; North America to account for 48% of market growth - Technavio

PR Newswire

NEW YORK, Jan. 24, 2023 /PRNewswire/ -- The Biotechnology Reagents Market by Technology, Application, and Geography - Forecast and Analysis 2023-2027 report has been published by Technavio. Market size is forecast to grow by USD 36,019.44 million between 2022 and 2027 at a CAGR of 7.51%. The report provides a comprehensive analysis of growth opportunities at regional levels, new product launches, the latest trends, and the post-pandemic recovery of the global market. Download A PDF Sample Report

Regional Analysis

By region, the global biotechnology reagents market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America will account for 48% of market growth during the forecast period. Factors such as ongoing research in biological sciences, investments by various biotechnology companies, and high demand for biotechnology reagents are driving the growth of the biotechnology reagents market in North America. Buy the report

Company Profiles

The biotechnology reagents market report includes information on the key products and recent developments of leading vendors, including:

  • Danaher Corp. - The company offers biotechnology reagents that are engineered to deliver reduced spillover to optimize resolution when used with other fluorochromes.
  • F. Hoffmann La Roche Ltd. - The company offers biotechnology reagents that include active ingredients for diagnostic assay which include nucleic acid isolation and purification, to enzymes for amplification and nucleotides.
  • Lonza Group Ltd. - The company offers biotechnology reagents that are required for the growth of Endothelial Cells.
  • Merck KGaA - The company offers biotechnology reagents that are subjected to stringent controls during development and production to ensure reliable and reproducible results.

Market Dynamics

The market is driven by factors such as the high usage of biotechnology reagents in diagnostic and therapeutic applications, increasing research and development investments by federal agencies and biotechnology firms, and the presence of high throughput and novel technologies. However, stringent regulations are hindering market growth.

Competitive Analysis

The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample

Market Segmentation

  • By technology, the market is segmented into chromatography, in-vitro diagnostics, polymerase chain reaction, cell culture, and others. The chromatography segment accounted for the largest share of the market in 2022.
  • By geography, the market is segmented into North America, Europe, Asia, and Rest of World (ROW). North America held the largest share of the market in 2022.

Related Reports:

  • The genomics market is estimated to grow at a CAGR of 10.53% between 2022 and 2027. The size of the market is forecast to increase by USD 18,244.34 million. The increasing demand for creating and upgrading genome databases is notably driving the market growth, although factors such as the shortage of skilled genetics professionals may impede the market growth.
  • The microbiomes market is estimated to grow at a CAGR of 21.95% between 2022 and 2027. The size of the market is forecast to increase by USD 891.94 million. The increasing prevalence of diseases is notably driving the market growth, although factors such as challenges related to manufacturing and formulation may impede the market growth.

Technavio's library includes over 17,000+ reports, covering more than 2,000 emerging technologies. Subscribe to our "Basic Plan" at just USD 5,000 and get lifetime access to Technavio Insights

What are the key data covered in this biotechnology reagents market report?

  • CAGR of the market during the forecast period.
  • Detailed information on factors that will drive the growth of the market between 2023 and 2027
  • Precise estimation of the size of the biotechnology reagents market and its contribution to the parent market.
  • Accurate predictions about upcoming trends and changes in consumer behavior.
  • Growth of the market across North America, Europe, Asia, and Rest of World (ROW).
  • A thorough analysis of the market's competitive landscape and detailed information about vendors.
  • Comprehensive analysis of factors that will challenge the growth of biotechnology reagents market vendors. 

Biotechnology Reagents Market Scope

Report Coverage

Details

Page number

180

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 7.51%

Market growth 2023-2027

USD 36,019.44 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.89

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 48%

Key countries

US, Germany, France, China, and Japan

Competitive landscape

Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Agilent Technologies Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., bioMerieux SA, Danaher Corp., F. Hoffmann La Roche Ltd., Illumina Inc., Lonza Group Ltd., Merck KGaA, Meridian Bioscience Inc., New England Biolabs Inc., PerkinElmer Inc., Promega Corp., QIAGEN NV, Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Waters Corp., and Tosoh Corp.

Market dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of contents:

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Technology
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
  • 3.4 Market outlook: Forecast for 2022-2027 
    • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
    • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
    • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

  • 4.1 Global biotechnology reagents market 2017 - 2021
    • Exhibit 18: Historic Market Size – Data Table on Global biotechnology reagents market 2017 - 2021 ($ million)
  • 4.2 Technology Segment Analysis 2017 - 2021
    • Exhibit 19: Historic Market Size – Technology Segment 2017 - 2021 ($ million)
  • 4.3 Application Segment Analysis 2017 - 2021
    • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
  • 4.4 Geography Segment Analysis 2017 - 2021 
    • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
  • 4.5 Country Segment Analysis 2017 - 2021 
    • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

  • 5.1 Five forces summary 
    • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
  • 5.2 Bargaining power of buyers 
    • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
  • 5.3 Bargaining power of suppliers 
    • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
  • 5.4 Threat of new entrants 
    • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
  • 5.5 Threat of substitutes 
    • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
  • 5.6 Threat of rivalry 
    • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
  • 5.7 Market condition 
    • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Technology

  • 6.1 Market segments 
    • Exhibit 30: Chart on Technology - Market share 2022-2027 (%)
    • Exhibit 31: Data Table on Technology - Market share 2022-2027 (%)
  • 6.2 Comparison by Technology 
    • Exhibit 32: Chart on Comparison by Technology
    • Exhibit 33: Data Table on Comparison by Technology
  • 6.3 Chromatography - Market size and forecast 2022-2027
    • Exhibit 34: Chart on Chromatography - Market size and forecast 2022-2027 ($ million)
    • Exhibit 35: Data Table on Chromatography - Market size and forecast 2022-2027 ($ million)
    • Exhibit 36: Chart on Chromatography - Year-over-year growth 2022-2027 (%)
    • Exhibit 37: Data Table on Chromatography - Year-over-year growth 2022-2027 (%)
  • 6.4 In-vitro diagnostics - Market size and forecast 2022-2027
    • Exhibit 38: Chart on In-vitro diagnostics - Market size and forecast 2022-2027 ($ million)
    • Exhibit 39: Data Table on In-vitro diagnostics - Market size and forecast 2022-2027 ($ million)
    • Exhibit 40: Chart on In-vitro diagnostics - Year-over-year growth 2022-2027 (%)
    • Exhibit 41: Data Table on In-vitro diagnostics - Year-over-year growth 2022-2027 (%)
  • 6.5 Polymerase chain reaction - Market size and forecast 2022-2027 
    • Exhibit 42: Chart on Polymerase chain reaction - Market size and forecast 2022-2027 ($ million)
    • Exhibit 43: Data Table on Polymerase chain reaction - Market size and forecast 2022-2027 ($ million)
    • Exhibit 44: Chart on Polymerase chain reaction - Year-over-year growth 2022-2027 (%)
    • Exhibit 45: Data Table on Polymerase chain reaction - Year-over-year growth 2022-2027 (%)
  • 6.6 Cell culture - Market size and forecast 2022-2027
    • Exhibit 46: Chart on Cell culture - Market size and forecast 2022-2027 ($ million)
    • Exhibit 47: Data Table on Cell culture - Market size and forecast 2022-2027 ($ million)
    • Exhibit 48: Chart on Cell culture - Year-over-year growth 2022-2027 (%)
    • Exhibit 49: Data Table on Cell culture - Year-over-year growth 2022-2027 (%)
  • 6.7 Others - Market size and forecast 2022-2027
    • Exhibit 50: Chart on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 51: Data Table on Others - Market size and forecast 2022-2027 ($ million)
    • Exhibit 52: Chart on Others - Year-over-year growth 2022-2027 (%)
    • Exhibit 53: Data Table on Others - Year-over-year growth 2022-2027 (%)
  • 6.8 Market opportunity by Technology 
    • Exhibit 54: Market opportunity by Technology ($ million)

7 Market Segmentation by Application

  • 7.1 Market segments 
    • Exhibit 55: Chart on Application - Market share 2022-2027 (%)
    • Exhibit 56: Data Table on Application - Market share 2022-2027 (%)
  • 7.2 Comparison by Application 
    • Exhibit 57: Chart on Comparison by Application
    • Exhibit 58: Data Table on Comparison by Application
  • 7.3 Protein synthesis and purification - Market size and forecast 2022-2027 
    • Exhibit 59: Chart on Protein synthesis and purification - Market size and forecast 2022-2027 ($ million)
    • Exhibit 60: Data Table on Protein synthesis and purification - Market size and forecast 2022-2027 ($ million)
    • Exhibit 61: Chart on Protein synthesis and purification - Year-over-year growth 2022-2027 (%)
    • Exhibit 62: Data Table on Protein synthesis and purification - Year-over-year growth 2022-2027 (%)
  • 7.4 Gene expression - Market size and forecast 2022-2027
    • Exhibit 63: Chart on Gene expression - Market size and forecast 2022-2027 ($ million)
    • Exhibit 64: Data Table on Gene expression - Market size and forecast 2022-2027 ($ million)
    • Exhibit 65: Chart on Gene expression - Year-over-year growth 2022-2027 (%)
    • Exhibit 66: Data Table on Gene expression - Year-over-year growth 2022-2027 (%)
  • 7.5 DNA and RNA analysis - Market size and forecast 2022-2027
    • Exhibit 67: Chart on DNA and RNA analysis - Market size and forecast 2022-2027 ($ million)
    • Exhibit 68: Data Table on DNA and RNA analysis - Market size and forecast 2022-2027 ($ million)
    • Exhibit 69: Chart on DNA and RNA analysis - Year-over-year growth 2022-2027 (%)
    • Exhibit 70: Data Table on DNA and RNA analysis - Year-over-year growth 2022-2027 (%)
  • 7.6 Drug testing - Market size and forecast 2022-2027
    • Exhibit 71: Chart on Drug testing - Market size and forecast 2022-2027 ($ million)
    • Exhibit 72: Data Table on Drug testing - Market size and forecast 2022-2027 ($ million)
    • Exhibit 73: Chart on Drug testing - Year-over-year growth 2022-2027 (%)
    • Exhibit 74: Data Table on Drug testing - Year-over-year growth 2022-2027 (%)
  • 7.7 Market opportunity by Application 
    • Exhibit 75: Market opportunity by Application ($ million)

8 Customer Landscape

  • 8.1 Customer landscape overview 
    • Exhibit 76: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

  • 9.1 Geographic segmentation 
    • Exhibit 77: Chart on Market share by geography 2022-2027 (%)
    • Exhibit 78: Data Table on Market share by geography 2022-2027 (%)
  • 9.2 Geographic comparison 
    • Exhibit 79: Chart on Geographic comparison
    • Exhibit 80: Data Table on Geographic comparison
  • 9.3 North America - Market size and forecast 2022-2027
    • Exhibit 81: Chart on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 82: Data Table on North America - Market size and forecast 2022-2027 ($ million)
    • Exhibit 83: Chart on North America - Year-over-year growth 2022-2027 (%)
    • Exhibit 84: Data Table on North America - Year-over-year growth 2022-2027 (%)
  • 9.4 Europe - Market size and forecast 2022-2027
    • Exhibit 85: Chart on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 86: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
    • Exhibit 87: Chart on Europe - Year-over-year growth 2022-2027 (%)
    • Exhibit 88: Data Table on Europe - Year-over-year growth 2022-2027 (%)
  • 9.5 Asia - Market size and forecast 2022-2027
    • Exhibit 89: Chart on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 90: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
    • Exhibit 91: Chart on Asia - Year-over-year growth 2022-2027 (%)
    • Exhibit 92: Data Table on Asia - Year-over-year growth 2022-2027 (%)
  • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
    • Exhibit 93: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 94: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
    • Exhibit 95: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • Exhibit 96: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
  • 9.7 US - Market size and forecast 2022-2027
    • Exhibit 97: Chart on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 98: Data Table on US - Market size and forecast 2022-2027 ($ million)
    • Exhibit 99: Chart on US - Year-over-year growth 2022-2027 (%)
    • Exhibit 100: Data Table on US - Year-over-year growth 2022-2027 (%)
  • 9.8 China - Market size and forecast 2022-2027
    • Exhibit 101: Chart on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 102: Data Table on China - Market size and forecast 2022-2027 ($ million)
    • Exhibit 103: Chart on China - Year-over-year growth 2022-2027 (%)
    • Exhibit 104: Data Table on China - Year-over-year growth 2022-2027 (%)
  • 9.9 Germany - Market size and forecast 2022-2027
    • Exhibit 105: Chart on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 106: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
    • Exhibit 107: Chart on Germany - Year-over-year growth 2022-2027 (%)
    • Exhibit 108: Data Table on Germany - Year-over-year growth 2022-2027 (%)
  • 9.10 France - Market size and forecast 2022-2027
    • Exhibit 109: Chart on France - Market size and forecast 2022-2027 ($ million)
    • Exhibit 110: Data Table on France - Market size and forecast 2022-2027 ($ million)
    • Exhibit 111: Chart on France - Year-over-year growth 2022-2027 (%)
    • Exhibit 112: Data Table on France - Year-over-year growth 2022-2027 (%)
  • 9.11 Japan - Market size and forecast 2022-2027
    • Exhibit 113: Chart on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 114: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
    • Exhibit 115: Chart on Japan - Year-over-year growth 2022-2027 (%)
    • Exhibit 116: Data Table on Japan - Year-over-year growth 2022-2027 (%)
  • 9.12 Market opportunity by geography 
    • Exhibit 117: Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

  • 10.1 Market drivers
  • 10.2 Market challenges
  • 10.3 Impact of drivers and challenges 
    • Exhibit 118: Impact of drivers and challenges in 2022 and 2027
  • 10.4 Market trends

11 Vendor Landscape

  • 11.1 Overview
  • 11.2 Vendor landscape 
    • Exhibit 119: Overview on Criticality of inputs and Factors of differentiation
  • 11.3 Landscape disruption 
    • Exhibit 120: Overview on factors of disruption
  • 11.4 Industry risks 
    • Exhibit 121: Impact of key risks on business

12 Vendor Analysis

  • 12.1 Vendors covered 
    • Exhibit 122: Vendors covered
  • 12.2 Market positioning of vendors 
    • Exhibit 123: Matrix on vendor position and classification
  • 12.3 Abbott Laboratories 
    • Exhibit 124: Abbott Laboratories - Overview
    • Exhibit 125: Abbott Laboratories - Business segments
    • Exhibit 126: Abbott Laboratories - Key news
    • Exhibit 127: Abbott Laboratories - Key offerings
    • Exhibit 128: Abbott Laboratories - Segment focus
  • 12.4 Agilent Technologies Inc. 
    • Exhibit 129: Agilent Technologies Inc. - Overview
    • Exhibit 130: Agilent Technologies Inc. - Business segments
    • Exhibit 131: Agilent Technologies Inc. - Key news
    • Exhibit 132: Agilent Technologies Inc. - Key offerings
    • Exhibit 133: Agilent Technologies Inc. - Segment focus
  • 12.5 Becton Dickinson and Co. 
    • Exhibit 134: Becton Dickinson and Co. - Overview
    • Exhibit 135: Becton Dickinson and Co. - Business segments
    • Exhibit 136: Becton Dickinson and Co. - Key news
    • Exhibit 137: Becton Dickinson and Co. - Key offerings
    • Exhibit 138: Becton Dickinson and Co. - Segment focus
  • 12.6 Bio Rad Laboratories Inc. 
    • Exhibit 139: Bio Rad Laboratories Inc. - Overview
    • Exhibit 140: Bio Rad Laboratories Inc. - Business segments
    • Exhibit 141: Bio Rad Laboratories Inc. - Key news
    • Exhibit 142: Bio Rad Laboratories Inc. - Key offerings
    • Exhibit 143: Bio Rad Laboratories Inc. - Segment focus
  • 12.7 bioMerieux SA 
    • Exhibit 144: bioMerieux SA - Overview
    • Exhibit 145: bioMerieux SA - Product / Service
    • Exhibit 146: bioMerieux SA - Key offerings
  • 12.8 Danaher Corp. 
    • Exhibit 147: Danaher Corp. - Overview
    • Exhibit 148: Danaher Corp. - Business segments
    • Exhibit 149: Danaher Corp. - Key news
    • Exhibit 150: Danaher Corp. - Key offerings
    • Exhibit 151: Danaher Corp. - Segment focus
  • 12.9 F. Hoffmann La Roche Ltd. 
    • Exhibit 152: F. Hoffmann La Roche Ltd. - Overview
    • Exhibit 153: F. Hoffmann La Roche Ltd. - Business segments
    • Exhibit 154: F. Hoffmann La Roche Ltd. - Key news
    • Exhibit 155: F. Hoffmann La Roche Ltd. - Key offerings
    • Exhibit 156: F. Hoffmann La Roche Ltd. - Segment focus
  • 12.10 Lonza Group Ltd. 
    • Exhibit 157: Lonza Group Ltd. - Overview
    • Exhibit 158: Lonza Group Ltd. - Business segments
    • Exhibit 159: Lonza Group Ltd. - Key news
    • Exhibit 160: Lonza Group Ltd. - Key offerings
    • Exhibit 161: Lonza Group Ltd. - Segment focus
  • 12.11 Merck KGaA 
    • Exhibit 162: Merck KGaA - Overview
    • Exhibit 163: Merck KGaA - Business segments
    • Exhibit 164: Merck KGaA - Key news
    • Exhibit 165: Merck KGaA - Key offerings
    • Exhibit 166: Merck KGaA - Segment focus
  • 12.12 Meridian Bioscience Inc. 
    • Exhibit 167: Meridian Bioscience Inc. - Overview
    • Exhibit 168: Meridian Bioscience Inc. - Business segments
    • Exhibit 169: Meridian Bioscience Inc. - Key offerings
    • Exhibit 170: Meridian Bioscience Inc. - Segment focus
  • 12.13 PerkinElmer Inc. 
    • Exhibit 171: PerkinElmer Inc. - Overview
    • Exhibit 172: PerkinElmer Inc. - Business segments
    • Exhibit 173: PerkinElmer Inc. - Key news
    • Exhibit 174: PerkinElmer Inc. - Key offerings
    • Exhibit 175: PerkinElmer Inc. - Segment focus
  • 12.14 Promega Corp. 
    • Exhibit 176: Promega Corp. - Overview
    • Exhibit 177: Promega Corp. - Product / Service
    • Exhibit 178: Promega Corp. - Key offerings
  • 12.15 Siemens AG 
    • Exhibit 179: Siemens AG - Overview
    • Exhibit 180: Siemens AG - Business segments
    • Exhibit 181: Siemens AG - Key news
    • Exhibit 182: Siemens AG - Key offerings
    • Exhibit 183: Siemens AG - Segment focus
  • 12.16 Sysmex Corp. 
    • Exhibit 184: Sysmex Corp. - Overview
    • Exhibit 185: Sysmex Corp. - Business segments
    • Exhibit 186: Sysmex Corp. - Key offerings
    • Exhibit 187: Sysmex Corp. - Segment focus
  • 12.17 Thermo Fisher Scientific Inc. 
    • Exhibit 188: Thermo Fisher Scientific Inc. - Overview
    • Exhibit 189: Thermo Fisher Scientific Inc. - Business segments
    • Exhibit 190: Thermo Fisher Scientific Inc. - Key news
    • Exhibit 191: Thermo Fisher Scientific Inc. - Key offerings
    • Exhibit 192: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

  • 13.1 Scope of the report
  • 13.2 Inclusions and exclusions checklist 
    • Exhibit 193: Inclusions checklist
    • Exhibit 194: Exclusions checklist
  • 13.3 Currency conversion rates for US$ 
    • Exhibit 195: Currency conversion rates for US$
  • 13.4 Research methodology 
    • Exhibit 196: Research methodology
    • Exhibit 197: Validation techniques employed for market sizing
    • Exhibit 198: Information sources
  • 13.5 List of abbreviations 
    • Exhibit 199: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/biotechnology-reagents-market-size-to-increase-by-usd-36-019-44-million-north-america-to-account-for-48-of-market-growth---technavio-301727948.html

SOURCE Technavio

Read More

Continue Reading

Uncategorized

Schedule for Week of January 29, 2023

The key reports scheduled for this week are the January employment report and November Case-Shiller house prices.Other key indicators include January ISM manufacturing and services surveys, and January vehicle sales.The FOMC meets this week, and the FO…

Published

on

The key reports scheduled for this week are the January employment report and November Case-Shiller house prices.

Other key indicators include January ISM manufacturing and services surveys, and January vehicle sales.

The FOMC meets this week, and the FOMC is expected to announce a 25 bp hike in the Fed Funds rate.

----- Monday, January 30th -----

10:30 AM: Dallas Fed Survey of Manufacturing Activity for January. This is the last of the regional Fed manufacturing surveys for January.

----- Tuesday, January 31st -----

9:00 AM: FHFA House Price Index for November. This was originally a GSE only repeat sales, however there is also an expanded index.

9:00 AM ET: S&P/Case-Shiller House Price Index for November.

This graph shows the Year over year change in the nominal seasonally adjusted National Index, Composite 10 and Composite 20 indexes through the most recent report (the Composite 20 was started in January 2000).

The consensus is for a 6.9% year-over-year increase in the Comp 20 index.

9:45 AM: Chicago Purchasing Managers Index for January. The consensus is for a reading of 44.9, down from 45.1 in December.

10:00 AM: The Q4 Housing Vacancies and Homeownership report from the Census Bureau.

----- Wednesday, February 1st -----

7:00 AM ET: The Mortgage Bankers Association (MBA) will release the results for the mortgage purchase applications index.

8:15 AM: The ADP Employment Report for January. This report is for private payrolls only (no government). The consensus is for 170,000 payroll jobs added in January, down from 235,000 added in December.

10:00 AM: Construction Spending for December. The consensus is for a 0.1% decrease in construction spending.

Job Openings and Labor Turnover Survey10:00 AM ET: Job Openings and Labor Turnover Survey for December from the BLS.

This graph shows job openings (black line), hires (purple), Layoff, Discharges and other (red column), and Quits (light blue column) from the JOLTS.

Job openings decreased in November to 10.458 million from 10.512 million in October

10:00 AM: ISM Manufacturing Index for January. The consensus is for the ISM to be at 48.0, down from 48.4 in December.

2:00 PM: FOMC Meeting Announcement. The FOMC is expected to announce a 25 bp hike in the Fed Funds rate.

2:30 PM: Fed Chair Jerome Powell holds a press briefing following the FOMC announcement.

Vehicle SalesAll day: Light vehicle sales for January. The consensus is for light vehicle sales to be 14.3 million SAAR in January, up from 13.3 million in December (Seasonally Adjusted Annual Rate).

This graph shows light vehicle sales since the BEA started keeping data in 1967. The dashed line is the December sales rate.

----- Thursday, February 2nd -----

8:30 AM: The initial weekly unemployment claims report will be released.  The consensus is for 200 thousand initial claims, up from 186 thousand last week.
----- Friday, February 3rd -----

Employment Recessions, Scariest Job Chart8:30 AM: Employment Report for December.   The consensus is for 185,000 jobs added, and for the unemployment rate to increase to 3.6%.

There were 223,000 jobs added in December, and the unemployment rate was at 3.5%.

This graph shows the job losses from the start of the employment recession, in percentage terms.

The pandemic employment recession was by far the worst recession since WWII in percentage terms. However, as of August 2022, the total number of jobs had returned and are now 1.24 million above pre-pandemic levels.

10:00 AM: ISM Manufacturing Index for January. The consensus is for the ISM to be at 50.3, up from 49.6 in December.

Read More

Continue Reading

Uncategorized

US gov’t $1.5T debt interest will be equal 3X Bitcoin market cap in 2023

The U.S. will pay over $1 trillion in debt interest next year, the equivalent of three or more Bitcoin market caps at current prices.

Published

on

The U.S. will pay over $1 trillion in debt interest next year, the equivalent of three or more Bitcoin market caps at current prices.

Commentators believe that Bitcoin (BTC) bulls do not need to wait long for the United States to start printing money again.

The latest analysis of U.S. macroeconomic data has led one market strategist to predict quantitative tightening (QT) ending to avoid a “catastrophic debt crisis.”

Analyst: Fed will have “no choice” with rate cuts

The U.S. Federal Reserve continues to remove liquidity from the financial system to fight inflation, reversing years of COVID-19-era money printing.

While interest rate hikes look set to continue declining in scope, some now believe that the Fed will soon have only one option — to halt the process altogether.

“Why the Fed will have no choice but to cut or risk a catastrophic debt crisis,” Sven Henrich, founder of NorthmanTrader, summarized on Jan. 27.

“Higher for longer is a fantasy not rooted in math reality.”

Henrich uploaded a chart showing interest payments on current U.S. government expenditure, now hurtling toward $1 trillion a year.

A dizzying number, the interest comes from U.S. government debt being over $31 trillion, with the Fed printing trillions of dollars since March 2020. Since then, interest payments have increased by 42%, Henrich noted.

The phenomenon has not gone unnoticed elsewhere in crypto circles. Popular Twitter account Wall Street Silver compared the interest payments as a portion of U.S. tax revenue.

“US paid $853 Billion in Interest for $31 Trillion Debt in 2022; More than Defense Budget in 2023. If the Fed keeps rates at these levels (or higher) we will be at $1.2 trillion to $1.5 trillion in interest paid on the debt,” it wrote.

“The US govt collects about $4.9 trillion in taxes.”
Interest rates on U.S. government debt chart (screenshot). Source: Wall Street Silver/ Twitter

Such a scenario might be music to the ears of those with significant Bitcoin exposure. Periods of “easy” liquidity have corresponded with increased appetite for risk assets across the mainstream investment world.

The Fed’s unwinding of that policy accompanied Bitcoin’s 2022 bear market, and a “pivot” in interest rate hikes is thus seen by many as the first sign of the “good” times returning.

Crypto pain before pleasure?

Not everyone, however, agrees that the impact on risk assets, including crypto, will be all-out positive prior to that.

Related: Bitcoin ‘so bullish’ at $23K as analyst reveals new BTC price metrics

As Cointelegraph reported, ex-BitMEX CEO Arthur Hayes believes that chaos will come first, tanking Bitcoin and altcoins to new lows before any sort of long-term renaissance kicks in.

If the Fed faces a complete lack of options to avoid a meltdown, Hayes believes that the damage will have already been done before QT gives way to quantitative easing.

“This scenario is less ideal because it would mean that everyone who is buying risky assets now would be in store for massive drawdowns in performance. 2023 could be just as bad as 2022 until the Fed pivots,” he wrote in a blog post this month.

The views, thoughts and opinions expressed here are the authors’ alone and do not necessarily reflect or represent the views and opinions of Cointelegraph.

Read More

Continue Reading

Uncategorized

Stay Ahead of GDP: 3 Charts to Become a Smarter Trader

When concerns of a recession are front and center, investors tend to pay more attention to the Gross Domestic Product (GDP) report. The Q4 2022 GDP report…

Published

on

When concerns of a recession are front and center, investors tend to pay more attention to the Gross Domestic Product (GDP) report. The Q4 2022 GDP report showed the U.S. economy grew by 2.9% in the quarter, and Wall Street wasn't disappointed. The day the report was released, the market closed higher, with the Dow Jones Industrial Average ($DJIA) up 0.61%, the S&P 500 index ($SPX) up 1.1%, and the Nasdaq Composite ($COMPQ) up 1.76%. Consumer Discretionary, Technology, and Energy were the top-performing S&P sectors.

Add to the GDP report strong earnings from Tesla, Inc. (TSLA) and a mega announcement from Chevron Corp. (CVX)—raising dividends and a $75 billion buyback round—and you get a strong day in the stock markets.

Why is the GDP Report Important?

If a country's GDP is growing faster than expected, it could be a positive indication of economic strength. It means that consumer spending, business investment, and exports, among other factors, are going strong. But the GDP is just one indicator, and one indicator doesn't necessarily tell the whole story. It's a good idea to look at other indicators, such as the unemployment rate, inflation, and consumer sentiment, before making a conclusion.

Inflation appears to be cooling, but the labor market continues to be strong. The Fed has stated in many of its previous meetings that it'll be closely watching the labor market. So that'll be a sticky point as we get close to the next Fed meeting. Consumer spending is also strong, according to the GDP report. But that could have been because of increased auto sales and spending on services such as health care, personal care, and utilities. Retail sales released earlier in January indicated that holiday sales were lower.

There's a chance we could see retail sales slowing in Q1 2023 as some households run out of savings that were accumulated during the pandemic. This is something to keep an eye on going forward, as a slowdown in retail sales could mean increases in inventories. And this is something that could decrease economic activity.

Overall, the recent GDP report indicates the U.S. economy is strong, although some economists feel we'll probably see some downside in 2023, though not a recession. But the one drawback of the GDP report is that it's lagging. It comes out after the fact. Wouldn't it be great if you had known this ahead of time so you could position your trades to take advantage of the rally? While there's no way to know with 100% accuracy, there are ways to identify probable events.

3 Ways To Stay Ahead of the Curve

Instead of waiting for three months to get next quarter's GDP report, you can gauge the potential strength or weakness of the overall U.S. economy. Steven Sears, in his book The Indomitable Investor, suggested looking at these charts:

  • Copper prices
  • High-yield corporate bonds
  • Small-cap stocks

Copper: An Economic Indicator

You may not hear much about copper, but it's used in the manufacture of several goods and in construction. Given that manufacturing and construction make up a big chunk of economic activity, the red metal is more important than you may have thought. If you look at the chart of copper futures ($COPPER) you'll see that, in October 2022, the price of copper was trading sideways, but, in November, its price rose and trended quite a bit higher. This would have been an indication of a strengthening economy.

CHART 1: COPPER CONTINUOUS FUTURES CONTRACTS. Copper prices have been rising since November 2022. Chart source: StockCharts.com. For illustrative purposes only.

High-Yield Bonds: Risk On Indicator

The higher the risk, the higher the yield. That's the premise behind high-yield bonds. In short, companies that are leveraged, smaller, or just starting to grow may not have the solid balance sheets that more established companies are likely to have. If the economy slows down, investors are likely to sell the high-yield bonds and pick up the safer U.S. Treasury bonds.

Why the flight to safety? It's because when the economy is sluggish, the companies that issue the high-yield bonds tend to find it difficult to service their debts. When the economy is expanding, the opposite happens—they tend to perform better.

The chart below of the Dow Jones Corporate Bond Index ($DJCB) shows that, since the end of October 2022, the index trended higher. Similar to copper prices, high-yield corporate bond activity was also indicating economic expansion. You'll see similar action in charts of high-yield bond exchange-traded funds (ETFs) such as iShares iBoxx $ High Yield Corporate Bond ETF (HYG) and SPDR Barclays High Yield Bond ETF (JNK).

CHART 2: HIGH-YIELD BONDS TRENDING HIGHER. The Dow Jones Corporate Bond Index ($DJCB) has been trending higher since end of October 2022.Chart source: StockCharts.com. For illustrative purposes only.

Small-Cap Stocks: They're Sensitive

Pull up a chart of the iShares Russell 2000 ETF (IWM) and you'll see similar price action (see chart 3). Since mid-October, small-cap stocks (the Russell 2000 index is made up of 2000 small companies) have been moving higher.

CHART 3: SMALL-CAP STOCKS TRENDING HIGHER. When the economy is expanding, small-cap stocks trend higher.Chart source: StockCharts.com. For illustrative purposes only.

Three's Company

If all three of these indicators are showing strength, you can expect the GDP number to be strong. There are times when the GDP number may not impact the markets, but, when inflation is a problem and the Fed is trying to curb it by raising interest rates, the GDP number tends to impact the markets.

This scenario is likely to play out in 2023, so it would be worth your while to set up a GDP Tracker ChartList. Want a live link to the charts used in this article? They're all right here.


Jayanthi Gopalakrishnan

Director, Site Content

StockCharts.com

 

Disclaimer: This blog is for educational purposes only and should not be construed as financial advice. The ideas and strategies should never be used without first assessing your own personal and financial situation, or without consulting a financial professional.

Read More

Continue Reading

Trending